ERBB Fusion
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (NCT03805841) | Rain Oncology Inc | 2019-03-13 |
Track ERBB Fusion automatically
Every clearance here is in the API, with alerts when new ones post.